This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Arthritis Therapeutics Market

Arthritis Therapeutics Market

Arthritis Therapeutics Market Analysis Repot By Type (Rheumatoid Arthritis, Osteoarthritis, Arthritis, Gout), By Drug Class, By Route of Administration, By Distribution Channel, By Region - Global Market Forecast to 2019-2027

Arthritis Therapeutics Market
FACT4355MR
  • Mar-2022
  • List of Tables : 30
  • List of Figures : 89
  • 170 Pages
  • Healthcare

Table of Content

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Arthritis Therapeutics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Arthritis Therapeutics Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key product/brand Analysis

    5.2. Pipeline Analysis

    5.3. Disease Prevalence & Incidence Rate globally with key countries

    5.4. Regulatory Scenario by Region/globally

6. Global Arthritis Therapeutics Market Analysis and Forecast, By Type 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

        6.3.1. Rheumatoid Arthritis

        6.3.2. Osteoarthritis

        6.3.3. Psoriatic Arthritis

        6.3.4. Gout

        6.3.5. Others

    6.4. Market Attractiveness By Type

7. Global Arthritis Therapeutics Market Analysis and Forecast, By Drug Class 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Drug Class, 2017–2027

        7.3.1. TNF Inhibitors

        7.3.2. Interleukin Inhibitors

        7.3.3. NSAIDs

        7.3.4. Corticosteroids

        7.3.5. Xanthine Oxidase Inhibitors

        7.3.6. Others

    7.4. Market Attractiveness By Drug Class 

8. Global Arthritis Therapeutics Market Analysis and Forecast, By Route of Administration 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Route of Administration, 2017–2027

        8.3.1. Oral

        8.3.2. Parenteral

        8.3.3. Topical 

    8.4. Market Attractiveness By Route of Administration 

9. Global Arthritis Therapeutics Market Analysis and Forecast, By Distribution Channel 

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Distribution Channel, 2017–2027

        9.3.1. Hospital Pharmacies

        9.3.2. Retail Pharmacies

        9.3.3. Online Pharmacies

    9.4. Market Attractiveness By Distribution Channel

10. Global Arthritis Therapeutics Market Analysis and Forecast, By Region 

    10.1. Key Findings

    10.2. Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Region

        10.2.1. North America

        10.2.2. Europe 

        10.2.3. Asia Pacific

        10.2.4. Latin America 

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness By Country/Sub-region /Region

11. North America Arthritis Therapeutics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Type, 2017–2027

        11.2.1. Rheumatoid Arthritis

        11.2.2. Osteoarthritis

        11.2.3. Psoriatic Arthritis

        11.2.4. Gout

        11.2.5. Others

    11.3. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Drug Class, 2017–2027

        11.3.1. TNF Inhibitors

        11.3.2. Interleukin Inhibitors

        11.3.3. NSAIDs

        11.3.4. Corticosteroids

        11.3.5. Xanthine Oxidase Inhibitors

        11.3.6. Others

    11.4. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Route of Administration, 2017–2027

        11.4.1. Oral

        11.4.2. Parenteral

        11.4.3. Topical 

    11.5. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Distribution Channel, 2017–2027

        11.5.1. Hospital Pharmacies

        11.5.2. Retail Pharmacies

        11.5.3. Online Pharmacies

    11.6. North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America Market Attractiveness Analysis

        11.7.1. By Type

        11.7.2. By Drug Class

        11.7.3. By Route of Administration

        11.7.4. By Distribution Channel

        11.7.5. By Country/Sub-region

12. Europe Arthritis Therapeutics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Type, 2017–2027

        12.2.1. Rheumatoid Arthritis

        12.2.2. Osteoarthritis

        12.2.3. Psoriatic Arthritis

        12.2.4. Gout

        12.2.5. Others

    12.3. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Drug Class, 2017–2027

        12.3.1. TNF Inhibitors

        12.3.2. Interleukin Inhibitors

        12.3.3. NSAIDs

        12.3.4. Corticosteroids

        12.3.5. Xanthine Oxidase Inhibitors

        12.3.6. Others

    12.4. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Route of Administration, 2017–2027

        12.4.1. Oral

        12.4.2. Parenteral

        12.4.3. Topical 

    12.5. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Distribution Channel, 2017–2027

        12.5.1. Hospital Pharmacies

        12.5.2. Retail Pharmacies

        12.5.3. Online Pharmacies

    12.6. Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Country/Sub-region, 2017–2027

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Europe Market Attractiveness Analysis

        12.7.1. By Type

        12.7.2. By Drug Class

        12.7.3. By Route of Administration

        12.7.4. By Distribution Channel

        12.7.5. By Country/Sub-region

13. Asia Pacific Arthritis Therapeutics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Type, 2017–2027

        13.2.1. Rheumatoid Arthritis

        13.2.2. Osteoarthritis

        13.2.3. Psoriatic Arthritis

        13.2.4. Gout

        13.2.5. Others

    13.3. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Drug Class, 2017–2027

        13.3.1. TNF Inhibitors

        13.3.2. Interleukin Inhibitors

        13.3.3. NSAIDs

        13.3.4. Corticosteroids

        13.3.5. Xanthine Oxidase Inhibitors

        13.3.6. Others

    13.4. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Route of Administration, 2017–2027

        13.4.1. Oral

        13.4.2. Parenteral

        13.4.3. Topical 

    13.5. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Distribution Channel, 2017–2027

        13.5.1. Hospital Pharmacies

        13.5.2. Retail Pharmacies

        13.5.3. Online Pharmacies

    13.6. Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region /Sub-region, 2017–2027

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific Market Attractiveness Analysis

        13.7.1. By Type

        13.7.2. By Drug Class

        13.7.3. By Route of Administration

        13.7.4. By Distribution Channel

        13.7.5. By Country/Sub-region

14. Latin America Arthritis Therapeutics Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Type, 2017–2027

        14.2.1. Rheumatoid Arthritis

        14.2.2. Osteoarthritis

        14.2.3. Psoriatic Arthritis

        14.2.4. Gout

        14.2.5. Others

    14.3. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Drug Class, 2017–2027

        14.3.1. TNF Inhibitors

        14.3.2. Interleukin Inhibitors

        14.3.3. NSAIDs

        14.3.4. Corticosteroids

        14.3.5. Xanthine Oxidase Inhibitors

        14.3.6. Others

    14.4. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Route of Administration, 2017–2027

        14.4.1. Oral

        14.4.2. Parenteral

        14.4.3. Topical 

    14.5. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Distribution Channel, 2017–2027

        14.5.1. Hospital Pharmacies

        14.5.2. Retail Pharmacies

        14.5.3. Online Pharmacies

    14.6. Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region /Sub-region, 2017–2027

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Latin America Market Attractiveness Analysis

        14.7.1. By Type

        14.7.2. By Drug Class

        14.7.3. By Route of Administration

        14.7.4. By Distribution Channel

        14.7.5. By Country/Sub-region 

15. Middle East & Africa Arthritis Therapeutics Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Type, 2017–2027

        15.2.1. Rheumatoid Arthritis

        15.2.2. Osteoarthritis

        15.2.3. Psoriatic Arthritis

        15.2.4. Gout

        15.2.5. Others

    15.3. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Drug Class, 2017–2027

        15.3.1. TNF Inhibitors

        15.3.2. Interleukin Inhibitors

        15.3.3. NSAIDs

        15.3.4. Corticosteroids

        15.3.5. Xanthine Oxidase Inhibitors

        15.3.6. Others

    15.4. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Route of Administration, 2017–2027

        15.4.1. Oral

        15.4.2. Parenteral

        15.4.3. Topical 

    15.5. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by  Distribution Channel, 2017–2027

        15.5.1. Hospital Pharmacies

        15.5.2. Retail Pharmacies

        15.5.3. Online Pharmacies

    15.6. Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region , 2017–2027

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Middle East & Africa Market Attractiveness Analysis

        15.7.1. By Type

        15.7.2. By Drug Class

        15.7.3. By Route of Administration

        15.7.4. By Distribution Channel

        15.7.5. By Country/Sub-region 

16. Competition Landscape

    16.1. Market Share Analysis By Company (2018)

    16.2. Company Profiles

        16.2.1. Novartis AG

        16.2.2. Eli Lilly and Company

        16.2.3. Amgen, Inc.

        16.2.4. Merck & Co., Inc.

        16.2.5. Bristol-Myers Squibb Company

        16.2.6. Pfizer, Inc. 

        16.2.7. AbbVie, Inc.

        16.2.8. Janssen Global Services, LLC (Johnson & Johnson)

        16.2.9. F. Hoffmann-La Roche Ltd

        16.2.10. Sanofi

Know More Details About the Report

List of Tables

Table 01: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 02: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 03: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 04: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 05: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017–2027

Table 07: North America Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 08: North America Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration,

Table 09: North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 10: North America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region , 2017–2027

Table 11: Europe Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017–2027

Table 12: Europe Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 13: Europe Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 14: Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 15: Europe Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017–2027

Table 16: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 17: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 18: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 19: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 20: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017–2027

Table 21: Latin America Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017–2027

Table 22: Latin America Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 23: Latin America Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 24: Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 25: Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017–2027

Table 26: Middle East & Africa Arthritis Therapeutics Value (US$ Mn) Forecast, by Type, 2017–2027

Table 27: Middle East & Africa Arthritis Therapeutics Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 28: Middle East & Africa Arthritis Therapeutics Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

Table 29: Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 30: Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017–2027

Have a report related query? Speak to us directly

List of Figures

Figure 01: Global Arthritis Therapeutics Market Snapshot

Figure 02: Global Arthritis Therapeutics Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 03: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast, 2017?2027

Figure 04: Global Arthritis Therapeutics Market Value Share (%), by Type (2018)

Figure 05: Global Arthritis Therapeutics Market Value Share (%), by Route of Administration (2018)

Figure 06: Global Arthritis Therapeutics Market Value Share (%), by Drug Class (2018)

Figure 07: Global Arthritis Therapeutics Market Value Share (%), by Distribution Channel (2018)

Figure 08: Global Arthritis Therapeutics Market Value Share (%), by Region (2018)

Figure 09: Global Arthritis Therapeutics Market Value Share Analysis, by Type, 2018 and 2027

Figure 10: Global Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027

Figure 11: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Rheumatoid Arthritis, 2017–2027

Figure 12: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Osteoarthritis, 2017–2027

Figure 13: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Psoriatic Arthritis, 2017–2027

Figure 14: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gout, 2017–2027

Figure 15: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027

Figure 16: Global Arthritis Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 17: Global Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027

Figure 18: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by TNF Inhibitors, 2017–2027

Figure 19: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Interleukin Inhibitors, 2017–2027

Figure 20: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by NSAIDs, 2017–2027

Figure 21: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids, 2017–2027

Figure 22: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Xanthine Oxidase Inhibitors, 2017–2027

Figure 23: Global Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027

Figure 24: Global Arthritis Therapeutics Market Value Share(%), by Route of Administration, 2018 and 2027

Figure 25: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2017–2027

Figure 26: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Parenteral, 2017–2027

Figure 27: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2017–2027

Figure 28: Global Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027

Figure 29: Global Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 30: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2017–2027

Figure 31: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2017–2027

Figure 32: Global Arthritis Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2017–2027

Figure 33: Global Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027

Figure 34: Global Arthritis Therapeutics Market Value Share Analysis, by Region 2018 and 2027

Figure 35: Global Arthritis Therapeutics Market Attractiveness, by Region, 2019–2027

Figure 36: North America Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 37: North America Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027

Figure 38: North America Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027

Figure 39: North America Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027

Figure 40: North America Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027

Figure 41: North America Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 42: North America Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027

Figure 43: North America Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 44: North America Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027

Figure 45 : North America Arthritis Therapeutics Market Value Share (%), By Country/Sub-region , 2018 and 2027

Figure 46: North America Arthritis Therapeutics Market Attractiveness, By Country/Sub-region , 2019–2027

Figure 47: Europe Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 48: Europe Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027

Figure 49: Europe Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027

Figure 50: Europe Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027

Figure 51: Europe Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027

Figure 52: Europe Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 53: Europe Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027

Figure 54: Europe Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 55: Europe Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027

Figure 56: Europe Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027

Figure 57: Europe Arthritis Therapeutics Market Attractiveness, By Country/Sub-region /Sub-region, 2019–2027

Figure 58: Asia Pacific Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 59: Asia Pacific Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027

Figure 60: Asia Pacific Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027

Figure 61: Asia Pacific Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027

Figure 62: Asia Pacific Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027

Figure 63: Asia Pacific Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 64: Asia Pacific Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027

Figure 65: Asia Pacific Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 66: Asia Pacific Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027

Figure 67 : Asia Pacific Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027

Figure 68: Asia Pacific Arthritis Therapeutics Market Attractiveness, By Country/Sub-region /Sub-region, 2019–2027

Figure 69: Latin America Arthritis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 70: Latin America Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027

Figure 71: Latin America Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027

Figure 72: Latin America Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027

Figure 73: Latin America Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027

Figure 74: Latin America Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 75: Latin America Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027

Figure 76: Latin America Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 77: Latin America Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027

Figure 78 : Latin America Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027

Figure 79: Latin America Arthritis Therapeutics Market Attractiveness, By Country/Sub-region /Sub-region, 2019–2027

Figure 80: Middle East & Africa Arthritis Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 81: Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Type, 2018 and 2027

Figure 82: Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Type, 2019–2027

Figure 83: Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Drug Class, 2018 and 2027

Figure 84: Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Drug Class, 2019–2027

Figure 85: Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 86: Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Route of Administration, 2019–2027

Figure 87: Middle East & Africa Arthritis Therapeutics Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 88: Middle East & Africa Arthritis Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027

Figure 89: Middle East & Africa Arthritis Therapeutics Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027

Arthritis Therapeutics Market - Scope of the Study

Fact.MR, in its exclusive research report on the arthritis therapeutics market, highlights actionable insights and winning imperatives for stakeholders. This comprehensive study unfolds rare and distinguished intelligence regarding impactful dynamics, which directly or indirectly influence the growth of the arthritis therapeutics market during the forecast period (2020 - 2027).

With the help of crucial insights discussed in this study, stakeholders will gain a thorough idea regarding the growth trajectory of the arthritis therapeutics market.

This comprehensive study offers incisive data regarding the drivers, threats, restraints, and opportunities present in the arthritis therapeutics market. The study also recalibrates the impact of each of these dynamics to estimate the size of the arthritis therapeutics market for the given period.

Authors of the report have taken ample care to measure and include the relevance and impact of microeconomic as well as macroeconomic factors that hold potential to influence the growth of the arthritis therapeutics market during the forecast period.

The global study offers crucial information about global, regional, and local players operating in the arthritis therapeutics market, along with their estimated market share. Market share has been estimated in terms of value (US$ Mn).

Besides providing key information regarding the concentration of leading, prominent, and local players, the study also aims at equipping stakeholders with the best of information regarding winning strategies, recent developments, and financials.

Key players profiled in this comprehensive study on the arthritis therapeutics market include Sanofi, Novartis AG, F.Hoffmann-La Roche Ltd, Eli Lily and Company, Janssen Global Services, LLC, Amgen, Inc., AbbVie, Inc., Amgen, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, and Merck & Co., Inc.

Arthritis Therapeutics Market - Research Methodology

The research undertaken by seasoned analysts at Fact.MR consists of a systematic approach. A combination of the bottom-up and top-down approach is leveraged to estimate the size of the arthritis therapeutics market.

Besides this, primary and secondary researches are carried out through credible sources to gain crucial insights into the arthritis therapeutics market. For conducting primary research, interviews and discussions were carried out with industry experts, key opinion leaders, vendors, and distributors.

Besides these, respondents also include CEOs, presidents, directors, chairmen, vice presidents, marketing managers, suppliers, distributors, and chief medical officers, among others. This helps in assessing the demand-supply gap prevailing in the arthritis therapeutics market.

In order to conduct secondary research, marketing collaterals, company websites, industry associations, and government statistics were studied. In addition to this, reports as well as content pieces published by credible sources, such as company annual reports, investor presentations, and SEC-filings were studied.

Besides this, governmental and public portals, such as World Health Organization (WHO), OECD, FDA, Centres of Disease Control and Prevention (CDC), the Centres for Medicare & Medicaid Services, MoHFW, Government of India, Dermatology News, Arthritis Foundation, National Psoriasis Foundation, Arthritis Foundation, Psoriasis Association, European Societies of Dermatology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and National Centre for Complementary and Integrative Health were referred to, in order to gain crucial information regarding key players in the arthritis therapeutics market. Insights obtained through primary and secondary research are then authenticated with the data triangulation method.

- FAQs -

The arthritis therapeutics market, authors of the report have segmented the landscape on the basis of type, drug class, route of administration, distribution channel, and region.
Arthritis therapeutics market is estimated to grow 1.5x during the forecast period (2020 - 2027).

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Natural Gelling Agents Market

Natural Gelling Agents Market is forecast to reach a valuation of US$ 6.33 Bn by 2032. Gelatin as a ...

Natural Industrial Absorbents Market

Natural Industrial Absorbents market is set to witness steady growth during 2029. Household applicat...

Natural Cheese Market

Natural Cheese Market to reach a valuation of US$ 8 Billion by the end of the year 2022. Goat milk b...

Natural Food Color Market

Natural Food Color Market is poised to reach US$ 17 Billion, over 7% CAGR from 2021 to 2031. Rising ...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.